## üßæ  `cases_malaysia_filtered_10cols.csv` ‚Äî columns:

* date
* cases_new
* cases_active
* cases_recovered
* cases_import
* cases_unvax
* cases_pvax
* cases_fvax
* cases_boost
* cases_adult

**‡¶ß‡¶∞‡¶ø final RQ:**

> **‚ÄúIs there a significant difference in average daily COVID-19 new cases in Malaysia before and after the national vaccination rollout?‚Äù**

---

# 1. Introduction

### 1.1 Problem statement and research motivation

‡¶è‡¶ñ‡¶æ‡¶®‡ßá ‡ßß‚Äì‡ß® ‡¶™‡ßç‡¶Ø‡¶æ‡¶∞‡¶æ‡¶ó‡ßç‡¶∞‡¶æ‡¶´‡ßá ‡¶≤‡¶ø‡¶ñ‡ßã:

* COVID-19 Malaysia‚Äì‡¶§‡ßá ‡¶ï‡ßÄ‡¶≠‡¶æ‡¶¨‡ßá ‡¶¨‡¶°‡¶º public health issue ‡¶õ‡¶ø‡¶≤
* ‡¶ï‡ßá‡¶® daily cases ‡¶¨‡ßã‡¶ù‡¶æ important
* Vaccination rollout‚Äì‡¶è‡¶∞ ‡¶Ü‡¶ó‡ßá/‡¶™‡¶∞‡ßá cases ‡¶™‡¶∞‡¶ø‡¶¨‡¶∞‡ßç‡¶§‡¶® ‡¶π‡¶Ø‡¶º‡ßá‡¶õ‡ßá ‡¶ï‡¶ø‡¶®‡¶æ ‚Üí policy, future pandemic planning ‡¶è‡¶∞ ‡¶ú‡¶®‡ßç‡¶Ø important
* ‡¶è‡¶ï ‡¶≤‡¶æ‡¶á‡¶®‡ßá main problem:

  * ‚ÄúWe want to investigate whether vaccination rollout was associated with a change in average daily reported cases.‚Äù

üëâ ‡¶è‡¶ñ‡¶æ‡¶®‡ßá ‡¶è‡¶ñ‡¶®‡¶ì numbers/plots ‡¶¶‡¶∞‡¶ï‡¶æ‡¶∞ ‡¶®‡ßá‡¶á, ‡¶∂‡ßÅ‡¶ß‡ßÅ context + ‡¶ï‡ßá‡¶® interesting‡•§

---

### 1.2 The data set

‡¶è‡¶ñ‡¶æ‡¶®‡ßá ‡¶≤‡¶ø‡¶ñ‡¶¨‡ßá:

* ‡¶°‡ßá‡¶ü‡¶æ‡¶∞ source:

  * Ministry of Health Malaysia public COVID-19 dataset (via GitHub / Kaggle mirror)
* Time period: 2020-01-25 ‡¶•‡ßá‡¶ï‡ßá 2023-08-19 ‡¶™‡¶∞‡ßç‡¶Ø‡¶®‡ßç‡¶§ (‡¶§‡ßÅ‡¶Æ‡¶ø summary ‡¶•‡ßá‡¶ï‡ßá ‡¶¶‡ßá‡¶ñ‡ßá‡¶õ‡ßã)
* ‡¶ï‡¶§‡¶ó‡ßÅ‡¶≤‡ßã row ‡¶Ü‡¶õ‡ßá (1303 days ‚Äì ‡¶è‡¶ü‡¶æ ‡¶§‡ßÅ‡¶Æ‡¶ø R/Python ‡¶¶‡¶ø‡¶Ø‡¶º‡ßá count ‡¶ï‡¶∞‡ßá ‡¶≤‡¶ø‡¶ñ‡¶§‡ßá ‡¶™‡¶æ‡¶∞‡ßã)
* ‡¶§‡ßÅ‡¶Æ‡¶ø **original dataset ‡¶•‡ßá‡¶ï‡ßá ‡¶∂‡ßÅ‡¶ß‡ßÅ ‡ßß‡ß¶‡¶ü‡¶æ column ‡¶∞‡ßá‡¶ñ‡ßá‡¶õ‡ßã** ‚Äî ‡¶è‡¶ó‡ßÅ‡¶≤‡ßã ‡¶≤‡¶ø‡¶∏‡ßç‡¶ü ‡¶ï‡¶∞‡ßá ‡¶¶‡¶æ‡¶ì ‡¶è‡¶¨‡¶Ç **‡¶™‡ßç‡¶∞‡¶§‡¶ø ‡¶ü‡¶æ‡¶∞ ‡ßß ‡¶≤‡¶æ‡¶á‡¶®‡ßá meaning ‡¶≤‡¶ø‡¶ñ‡ßã**

  * ‡¶Ø‡ßá‡¶Æ‡¶®:

    * `cases_new`: ‡¶®‡¶§‡ßÅ‡¶® confirm ‡¶ï‡¶∞‡¶æ daily cases
    * `cases_active`: active infections
    * `cases_recovered`: daily recovered cases
    * ‚Ä¶ ‡¶á‡¶§‡ßç‡¶Ø‡¶æ‡¶¶‡¶ø
* ‡¶ï‡ßá‡¶® ‡¶∏‡¶¨ ‡ß©‡ßß‡¶ü‡¶æ column ‡¶®‡¶æ ‡¶®‡¶ø‡¶Ø‡¶º‡ßá ‡ßß‡ß¶‡¶ü‡¶æ ‡¶®‡¶ø‡¶≤‡ßá, ‡¶è‡¶ï ‡¶≤‡¶æ‡¶á‡¶®‡ßá justify ‡¶ï‡¶∞‡ßã (‡¶®‡¶ø‡¶ú‡ßá‡¶∞ ‡¶≠‡¶æ‡¶∑‡¶æ‡¶Ø‡¶º, ‡¶Ø‡ßá‡¶Æ‡¶®):

  * ‚ÄúOnly variables directly related to overall case trends and vaccination status were retained to keep the analysis focused and relevant to the research question.‚Äù

---

### 1.3 Research question

‡¶è‡¶ñ‡¶æ‡¶®‡ßá ‡¶è‡¶ï ‡¶¨‡¶æ ‡¶¶‡ßÅ‡¶á ‡¶≤‡¶æ‡¶á‡¶®‡ßá ‡¶§‡ßã‡¶Æ‡¶æ‡¶∞ RQ ‡¶≤‡¶ø‡¶ñ‡¶¨‡ßá:

> ‚ÄúIs there a significant difference in the mean daily number of COVID-19 new cases in Malaysia before and after the national vaccination rollout?‚Äù

‡¶á‡¶ö‡ßç‡¶õ‡ßá ‡¶ï‡¶∞‡¶≤‡ßá date boundary mention ‡¶ï‡¶∞‡¶§‡ßá ‡¶™‡¶æ‡¶∞‡ßã (e.g. vaccination rollout around 24 Feb 2021)‡•§

---

### 1.4 Null hypothesis and alternative hypothesis (H0/H1)

‡¶è‡¶ñ‡¶æ‡¶®‡ßá ‡¶∏‡ßç‡¶™‡¶∑‡ßç‡¶ü ‡¶ï‡¶∞‡ßá ‡¶¶‡ßÅ‡¶á‡¶ü‡¶æ hypothesis ‡¶≤‡¶ø‡¶ñ‡¶¨‡ßá:

* **H‚ÇÄ (Null):**
  The mean daily number of new COVID-19 cases before vaccination rollout is equal to the mean after rollout.

* **H‚ÇÅ (Alternative):**
  The mean daily number of new COVID-19 cases before vaccination rollout is different from the mean after rollout.

‡¶è‡¶ï ‡¶≤‡¶æ‡¶á‡¶®‡ßá ‡¶≤‡¶ø‡¶ñ‡¶§‡ßá ‡¶™‡¶æ‡¶∞‡ßã:
‚ÄúIf p-value < 0.05, we will reject H‚ÇÄ in favour of H‚ÇÅ.‚Äù

---

# 2. Background research

### 2.1 Research papers (at least 3)

‡¶è‡¶ñ‡¶æ‡¶®‡ßá ‡¶§‡ßã‡¶Æ‡¶æ‡¶ï‡ßá **‡¶®‡¶ø‡¶ú‡ßá** ‡ß©‡¶ü‡¶æ paper ‡¶ñ‡ßÅ‡¶Å‡¶ú‡ßá ‡¶®‡¶ø‡¶§‡ßá ‡¶π‡¶¨‡ßá (Google Scholar / library ‡¶•‡ßá‡¶ï‡ßá), ‡¶Ø‡ßá‡¶Æ‡¶®:

* Malaysia COVID-19 wave patterns
* Impact of vaccination on COVID-19 transmission
* Time series analysis of COVID-19 cases

‡¶™‡ßç‡¶∞‡¶§‡¶ø paper ‡¶è‡¶∞ ‡¶ú‡¶®‡ßç‡¶Ø ‡¶≤‡¶ø‡¶ñ‡¶¨‡ßá:

* ‡ß®‚Äì‡ß© ‡¶≤‡¶æ‡¶á‡¶® summary: they studied what, method (short), key findings
* ‡ßß ‡¶≤‡¶æ‡¶á‡¶®: ‡¶ï‡ßÄ‡¶≠‡¶æ‡¶¨‡ßá ‡¶∏‡ßá‡¶ü‡¶æ ‡¶§‡ßã‡¶Æ‡¶æ‡¶∞ ‡¶ï‡¶æ‡¶ú‡ßá‡¶∞ ‡¶∏‡¶æ‡¶•‡ßá related

---

### 2.2 Why RQ is of interest (research gap & future)

‡¶è‡¶ñ‡¶æ‡¶®‡ßá ‡¶¨‡ßã‡¶ù‡¶æ‡¶¨‡ßá:

* ‡¶Ü‡¶ó‡ßá‡¶∞ ‡¶ï‡¶æ‡¶ú‡¶ó‡ßÅ‡¶≤‡ßã ‡¶ï‡ßÄ ‡¶ï‡¶∞‡ßá‡¶õ‡ßá (e.g. national level trend, modelling)
* **‡¶ó‡ßç‡¶Ø‡¶æ‡¶™**: ‡¶π‡ßü‡¶§‡ßã ‡¶Ö‡¶®‡ßá‡¶ï paper modelling ‡¶ï‡¶∞‡ßá‡¶õ‡ßá, ‡¶ï‡¶ø‡¶®‡ßç‡¶§‡ßÅ simple before‚Äìafter mean comparison ‡¶ï‡¶∞‡ßá‡¶®‡¶ø / certain period focus ‡¶ï‡¶∞‡ßá‡¶®‡¶ø
* ‡¶§‡ßã‡¶Æ‡¶æ‡¶∞ ‡¶ï‡¶æ‡¶ú ‡¶ï‡ßÄ contribution ‡¶¶‡¶ø‡¶ö‡ßç‡¶õ‡ßá (simple but clear evidence if average cases changed)
* Future direction:

  * ‡¶Ö‡¶®‡ßç‡¶Ø ‡¶¶‡ßá‡¶∂ compare ‡¶ï‡¶∞‡¶æ
  * State-level analysis
  * Age-group Î≥Ñ cases etc.

---

# 3. Visualisation

### 3.1 Appropriate plot for the RQ + required supplementary graphic

‡¶è‡¶ñ‡¶æ‡¶®‡ßá ‡¶§‡ßÅ‡¶Æ‡¶ø R ‡¶¶‡¶ø‡ßü‡ßá ‡¶¨‡¶æ‡¶®‡¶æ‡¶®‡ßã ‡¶™‡ßç‡¶≤‡¶ü embed ‡¶ï‡¶∞‡¶¨‡ßá + text ‡¶è ‡¶¨‡ßç‡¶Ø‡¶æ‡¶ñ‡ßç‡¶Ø‡¶æ ‡¶ï‡¶∞‡¶¨‡ßá‡•§

‡¶§‡ßã‡¶Æ‡¶æ‡¶∞ ‡¶ú‡¶®‡ßç‡¶Ø minimum set:

**Main plot (for RQ):**

* **Boxplot**

  * x-axis: group (‚ÄúBefore vaccination‚Äù, ‚ÄúAfter vaccination‚Äù)
  * y-axis: `cases_new`

Text ‡¶è explain ‡¶ï‡¶∞‡¶¨‡ßá:

* median, spread, outliers difference, visually ‡¶ï‡¶ø ‡¶¨‡ßã‡¶ù‡¶æ ‡¶Ø‡¶æ‡¶ö‡ßç‡¶õ‡ßá before vs after‚Äì‡¶è‡•§

**Required supplementary graphic: Histogram**

* Histogram of `cases_new`

  * ‡¶è‡¶ï‡¶ü‡¶æ overall histogram
  * Optionally, ‡¶¶‡ßÅ‡¶á‡¶ü‡¶æ ‡¶Ü‡¶≤‡¶æ‡¶¶‡¶æ histogram (before ‡¶è‡¶¨‡¶Ç after)

Explain ‡¶ï‡¶∞‡¶¨‡ßá:

* distribution skewed ‡¶®‡¶æ‡¶ï‡¶ø roughly normal
* ‡¶ï‡¶ø ‡¶Æ‡¶§‡ßã extreme peaks ‡¶õ‡¶ø‡¶≤ waves ‡¶∏‡¶Æ‡¶Ø‡¶º‡ßá

*(R code Appendix ‡¶è ‡¶•‡¶æ‡¶ï‡¶¨‡ßá, ‡¶è‡¶ñ‡¶æ‡¶®‡ßá ‡¶∂‡ßÅ‡¶ß‡ßÅ ‡¶ó‡ßç‡¶∞‡¶æ‡¶´ ‡¶Ü‡¶∞ explanation)*

---

### 3.2 Additional information (optional)

‡¶è‡¶ñ‡¶æ‡¶®‡ßá ‡ßß‚Äì‡ß®‡¶ü‡¶æ extra plot ‡¶¶‡¶ø‡¶≤‡ßá ‡¶≠‡¶æ‡¶≤‡ßã ‡¶®‡¶Æ‡ßç‡¶¨‡¶∞:

* Line plot:

  * x = date, y = cases_new
  * visualize ‡¶™‡ßÅ‡¶∞‡ßã ‡¶∏‡¶Æ‡¶Ø‡¶º‡ßá‡¶∞ trend, waves, peaks
* ‡¶Ü‡¶∞‡ßá‡¶ï‡¶ü‡¶æ: line plot for `cases_active` ‡¶¨‡¶æ `cases_boost`

Short text:

* ‚ÄúThis plot shows major waves around [months/years]. We also see that booster doses start rising in later period.‚Äù

---

### 3.3 Useful information for data understanding

‡¶è‡¶ñ‡¶æ‡¶®‡ßá summarise ‡¶ï‡¶∞‡¶¨‡ßá:

* Descriptive stats (mean, median, sd of `cases_new` before ‡¶è‡¶¨‡¶Ç after)
* Maybe small table:

| Group | Mean cases_new | SD | Min | Max |
| ----- | -------------- | -- | --- | --- |

‡¶è‡¶ó‡ßÅ‡¶≤‡ßã R-‡¶è‡¶∞ `summary()` ‡¶¨‡¶æ `dplyr` ‡¶¶‡¶ø‡¶Ø‡¶º‡ßá ‡¶ï‡¶∞‡¶¨‡ßá, ‡¶ü‡ßá‡¶¨‡¶ø‡¶≤ report ‡¶è ‡¶™‡ßá‡¶∏‡ßç‡¶ü ‡¶ï‡¶∞‡¶¨‡ßá‡•§

---

# 4. Analysis

### 4.1 Statistical test used & output

‡¶è‡¶ñ‡¶æ‡¶®‡ßá ‡¶§‡ßÅ‡¶Æ‡¶ø explain ‡¶ï‡¶∞‡¶¨‡ßá:

* ‡¶ï‡ßã‡¶® test use ‡¶ï‡¶∞‡¶õ‡ßã:

  * ‚ÄúIndependent two-sample t-test to compare mean daily cases before and after vaccination rollout.‚Äù
* ‡¶ï‡ßá‡¶® t-test valid:

  * ‡¶¶‡ßÅ‡¶á‡¶ü‡¶æ independent group
  * numeric outcome
  * sample size ‡¶¨‡ßú ‚Üí normality assumption less critical

‡¶§‡¶æ‡¶∞‡¶™‡¶∞:

* R t-test output ‡¶•‡ßá‡¶ï‡ßá:

  * t-statistic
  * degrees of freedom
  * p-value
  * confidence interval
  * group means

‡¶è‡¶∏‡¶¨ ‡¶∏‡¶Ç‡¶ñ‡ßç‡¶Ø‡¶æ ‡¶ü‡ßá‡¶ï‡ßç‡¶∏‡¶ü‡ßá ‡¶≤‡¶ø‡¶ñ‡¶¨‡ßá, ‡¶Ø‡ßá‡¶Æ‡¶®:

> ‚ÄúThe mean daily cases before rollout were XXXX, compared to YYYY after rollout.
> The t-test produced a t-statistic of ‚Ä¶ with p-value ‚Ä¶, indicating (no) statistically significant difference at the 5% level.‚Äù

(‡¶è‡¶á exact sentence ‡¶§‡ßÅ‡¶Æ‡¶ø ‡¶®‡¶ø‡¶ú‡ßá‡¶∞ ‡¶≠‡¶æ‡¶∑‡¶æ‡¶Ø‡¶º ‡¶≤‡¶ø‡¶ñ‡¶¨‡ßá, ‡¶Ü‡¶Æ‡¶ø ‡¶∂‡ßÅ‡¶ß‡ßÅ structure ‡¶¨‡ßÅ‡¶ù‡¶æ‡¶ö‡ßç‡¶õ‡¶ø‡•§)

---

### 4.2 H‚ÇÄ rejected / not rejected

‡¶è‡¶ñ‡¶æ‡¶®‡ßá ‡¶∂‡ßÅ‡¶ß‡ßÅ ‡¶™‡¶∞‡¶ø‡¶∑‡ßç‡¶ï‡¶æ‡¶∞ decision:

* ‡¶Ø‡¶¶‡¶ø p < 0.05 ‚Üí

  * ‚ÄúWe reject the null hypothesis and conclude that the average daily cases differ significantly before and after vaccination rollout.‚Äù

* ‡¶Ø‡¶¶‡¶ø p ‚â• 0.05 ‚Üí

  * ‚ÄúWe fail to reject the null hypothesis; the data do not provide sufficient evidence of a difference in mean daily cases.‚Äù

‡¶è‡¶ï‡¶á ‡¶∏‡¶ô‡ßç‡¶ó‡ßá ‡ßß‚Äì‡ß® ‡¶≤‡¶æ‡¶á‡¶®‡ßá **real-world meaning** explain ‡¶ï‡¶∞‡¶¨‡ßá‡•§

---

# 5. Evaluation ‚Äì group‚Äôs experience

‡¶è‡¶ü‡¶æ pure writing, data analysis ‡¶®‡¶æ‡•§

### 5.1 What went well

* Group communication, dataset selection, GitHub use, division of tasks
* R ‡¶∂‡ßá‡¶ñ‡¶æ/‡¶≠‡¶ø‡¶ú‡ßç‡¶Ø‡ßÅ‡¶Ø‡¶º‡¶æ‡¶≤‡¶æ‡¶á‡¶ú‡ßá‡¶∂‡¶® ‡¶§‡ßà‡¶∞‡¶ø ‡¶á‡¶§‡ßç‡¶Ø‡¶æ‡¶¶‡¶ø

### 5.2 Points for improvement

* Earlier start, better version control, more frequent meetings etc.

### 5.3 Time management

* ‡¶ï‡¶¨‡ßá ‡¶•‡ßá‡¶ï‡ßá ‡¶∂‡ßÅ‡¶∞‡ßÅ ‡¶ï‡¶∞‡ßá‡¶õ‡ßã
* deadline ‡¶è‡¶∞ ‡¶Ü‡¶ó‡ßá ‡¶ï‡¶§‡¶ü‡¶æ done ‡¶õ‡¶ø‡¶≤
* next time ‡¶ï‡ßÄ better ‡¶ï‡¶∞‡¶§‡ßá ‡¶™‡¶æ‡¶∞‡ßã

### 5.4 Project‚Äôs overall judgement

* ‡¶Ü‡¶™‡¶®‡¶æ‡¶∞‡¶æ ‡¶®‡¶ø‡¶ú‡ßá‡¶¶‡ßá‡¶∞ ‡¶ï‡¶æ‡¶ú‡¶ï‡ßá ‡¶ï‡ßÄ‡¶≠‡¶æ‡¶¨‡ßá rate ‡¶ï‡¶∞‡ßã
* strengths / weaknesses

### 5.5 Comment on GitHub log output

* ‡¶ï‡ßá ‡¶ï‡ßÄ commit ‡¶ï‡¶∞‡ßá‡¶õ‡ßá
* ‡¶∏‡¶¨‡¶æ‡¶á weekly contribute ‡¶ï‡¶∞‡ßá‡¶õ‡ßá ‡¶ï‡¶ø‡¶®‡¶æ
* log ‡¶•‡ßá‡¶ï‡ßá ‡¶ï‡ßÄ ‡¶¨‡ßã‡¶ù‡¶æ ‡¶Ø‡¶æ‡ßü (e.g. balanced contribution ‡¶¨‡¶æ last-minute rush)

---

# 6. Conclusions

### 6.1 Results explained

Short summary:

* RQ remind
* Key numerical findings (means, p-value)
* Direction (increased/decreased or no change)

### 6.2 Interpretation

* public health view: vaccination rollout ‡¶∏‡¶§‡ßç‡¶§‡ßç‡¶¨‡ßá‡¶ì cases wave ‡¶π‡¶Ø‡¶º‡ßá‡¶õ‡ßá ‡¶ï‡¶ø‡¶®‡¶æ
* ‡¶Ü‡¶™‡¶®‡¶æ‡¶∞ findings ‡¶ï‡¶ø intuitive ‡¶≤‡¶æ‡¶ó‡¶õ‡ßá?
* cases_boost, cases_unvax ‡¶á‡¶§‡ßç‡¶Ø‡¶æ‡¶¶‡¶ø‡¶∞ pattern ‡¶¶‡ßá‡¶ñ‡ßá ‡¶ï‡¶ø support ‡¶ï‡¶∞‡ßá?

### 6.3 Limitations, future work

* ‡¶∂‡ßÅ‡¶ß‡ßÅ‡¶Æ‡¶æ‡¶§‡ßç‡¶∞ national-level data
* ‡¶Ö‡¶®‡ßç‡¶Ø‡¶æ‡¶®‡ßç‡¶Ø factors consider ‡¶ï‡¶∞‡¶æ ‡¶π‡¶Ø‡¶º‡¶®‡¶ø (variants, policy, mobility)
* Future: state-level, age-specific, regression model etc.

---

# 7. Reference list (Harvard format)

‡¶è‡¶ñ‡¶æ‡¶®‡ßá:

* Dataset citation (MoH Malaysia repo + Kaggle page)
* ‡¶Ö‡¶®‡ßç‡¶§‡¶§ ‡ß©‡¶ü‡¶æ research paper
* ‡¶≠‡¶æ‡¶≤‡ßã ‡¶π‡¶≤‡ßá ‡ßß‚Äì‡ß®‡¶ü‡¶æ guideline/report (WHO, MoH Malaysia)

‡¶∏‡¶¨ Harvard style ‡¶è:

* Author (Year) Title. Source, etc.

---

# 8. Appendices

### A. R code

‡¶è‡¶ñ‡¶æ‡¶®‡ßá full R scripts:

* data load
* filtering / date split
* plots
* t-test

‡¶∏‡¶¨ nicely commented ‡¶•‡¶æ‡¶ï‡¶¨‡ßá‡•§

### B. GitHub log output

* GitHub ‡¶•‡ßá‡¶ï‡ßá commits list copy ‡¶ï‡¶∞‡ßá
* ‡¶§‡¶æ‡¶∞‡¶ø‡¶ñ + message ‡¶∏‡¶π paste ‡¶ï‡¶∞‡¶¨‡ßá‡•§

---

## ‡¶è‡¶ñ‡¶® ‡¶™‡ßç‡¶∞‡¶∂‡ßç‡¶®: **R script ‡¶ï‡ßã‡¶•‡¶æ‡¶Ø‡¶º ‡¶≤‡¶ø‡¶ñ‡¶¨‡ßá? Colab allow ‡¶ï‡¶∞‡ßá?**

### ‚úÖ Option 1 ‚Äî RStudio Desktop (Laptop ‡¶è install)

‡¶∏‡¶¨‡¶ö‡ßá‡¶Ø‡¶º‡ßá common ‡¶ì ‡¶∏‡¶π‡¶ú (especially for R module):

1. R + RStudio install ‡¶ï‡¶∞‡ßã
2. New Project ‚Üí ‡¶®‡¶§‡ßÅ‡¶® `.R` script
3. Code ‡¶≤‡¶ø‡¶ñ‡ßã, run ‡¶ï‡¶∞‡ßã, plots export ‡¶ï‡¶∞‡ßã
4. Final `.R` file ‡¶ü‡¶æ Appendix-‡¶è use ‡¶ï‡¶∞‡ßã

### ‚úÖ Option 2 ‚Äî Posit Cloud / RStudio Cloud (browser-based RStudio)

‡¶ï‡ßã‡¶®‡ßã install ‡¶≤‡¶æ‡¶ó‡¶¨‡ßá ‡¶®‡¶æ:

1. Posit Cloud ‡¶è account
2. New R Project
3. R script ‡¶≤‡¶ø‡¶ñ‡ßã, ‡¶è‡¶ï‡¶á RStudio interface
4. ‡¶™‡ßç‡¶≤‡¶ü download ‡¶ï‡¶∞‡ßá report-‡¶è ‡¶¨‡¶∏‡¶æ‡¶ì

‡¶è‡¶ü‡¶æ ‡¶Ö‡¶®‡ßá‡¶ï ‡¶á‡¶â‡¶®‡¶ø‡¶≠‡¶æ‡¶∞‡ßç‡¶∏‡¶ø‡¶ü‡¶ø use ‡¶ï‡¶∞‡ßá‡•§
 
